Search

Displaying results 8521 - 8530 of 10000 in total
  1. Drug

    Flizasertib

    go.drugbank.com/drugs/DB21613
    Investigational

    Flizasertib is under investigation in clinical trial NCT06602453 (A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse … The usage of the INN stem '-sertib' in the name indicates that Flizasertib is a serine/threonine kinase inhibitor.

  2. Drug

    NKX101

    go.drugbank.com/drugs/DB18131
    Investigational

    NKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.

    Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15
  3. Drug

    JQ1

    go.drugbank.com/drugs/DB17021
    Experimental

    First-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967]

  4. Drug

    Limonene, (+/-)-

    go.drugbank.com/drugs/DB19146
    Investigational

    Limonene, (+/-)- is under investigation in clinical trial NCT05525260 (Limonene for Pulmonary Nodule Chemoprevention).

  5. Drug

    Phenazepam

    go.drugbank.com/drugs/DB19164
    Investigational

    Phenazepam is under investigation in clinical trial NCT03017430 (Pregabalin for Opiate Withdrawal Syndrome).

  6. Drug

    Macozinone

    go.drugbank.com/drugs/DB14821
    Investigational

    Macozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169).

  7. Drug

    Flumatinib

    go.drugbank.com/drugs/DB11904
    Investigational

    Flumatinib has been used in trials studying the treatment of Myelogenous Leukemia, Chronic.

  8. Drug

    OBP-801

    go.drugbank.com/drugs/DB12279
    Investigational

    OBP-801 has been used in trials studying the treatment of Solid Tumor.

  9. Drug

    XL-888

    go.drugbank.com/drugs/DB12981
    Investigational

    XL888 has been used in trials studying the treatment of Cancer and Melanoma.

  10. Drug

    LY-518674

    go.drugbank.com/drugs/DB12988
    Investigational

    LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.